GovernAtlasSubmit your product ↗
Discover platforms/DeepScribe Inc.

GOVERNATLAS / PRODUCT DOSSIER

DeepScribe

DeepScribe describes AI medical scribing for specialty care. Its posted terms include a BAA, and its acceptable-use policy identifies the practice agreement as controlling patient-data handling.

Explore the product ↗Add to comparison ↗

01 / CONTEXT & SCOPE

Understand the proposition.
Define the boundary.

The decision to make

Evaluate DeepScribe for the specific documentation and clinician-review workflow you intend to use. Define who may handle the data and approve the result before considering efficiency claims.

What this record does not establish

Posted terms contain a BAA. The practice's agreement governs PHI handling, and order-form/service scope must be confirmed. AI output requires clinical review. The public statements remain vendor attributed; no executed customer agreement, clinical validation or independent security testing is established.

3 current sources · 3 published assertions
Source coverage is a research boundary, not a quality score.

02 / YOUR EVALUATION

Turn interest into a useful trial.

Open the evaluation playbook ↗
A

A test worth running

Use a synthetic specialty encounter containing a negated symptom, a changed dosage and an interrupted recording. Compare the generated draft with the scenario, document corrections and verify who approves the final test record.

GovernAtlas editorial proposal. We have not performed this test.

B

Evidence to bring back

  1. Retain the synthetic scenario, generated draft, corrections and clinical reviewer decision.
  2. Obtain the applicable agreement version, service and integration boundary before sharing PHI.
  3. Assign owners and dates for unresolved consent, retention, training-use and exit questions.

03 / DOCUMENTED EVIDENCE

Read the claim. Inspect the basis.

Each statement retains its classification and preserved source. A vendor assertion is not an independent test result.

01
vendor asserted

DeepScribe's acceptable-use policy says the practice BAA governs patient-data handling and takes precedence over conflicting provisions in that policy. This is a contractual statement, not a control test or a finding of compliant deployment.

Source, dates & preserved provenanceDeepScribe Inc. — Official product overview ↗

Authority: vendor owned
Observed 2026-11-02 · Reviewed 2026-11-02 · current until 2026-12-02

Artifact SHA-256: 44db707b642682e065bd27a6be1c100c9c4cacce8e19cb8c18c4b60bd0216560

The hash identifies the preserved capture. The live source may have changed.

02
vendor asserted

DeepScribe's posted terms include a HIPAA business-associate agreement between DeepScribe and its healthcare customer. Buyers must confirm the applicable service and order form; the published text is not evidence that their own BAA has been executed.

Source, dates & preserved provenanceDeepScribe Inc. — Posted platform terms and HIPAA provisions ↗

Authority: vendor owned
Observed 2026-11-02 · Reviewed 2026-11-02 · current until 2026-12-02

Artifact SHA-256: 03ae3aa77d035c1ce8a81dd081568d354bd7e88a1a0af62af650e3752e99e807

The hash identifies the preserved capture. The live source may have changed.

03
vendor asserted

DeepScribe describes an AI medical scribe and pre-visit tools for specialty-care workflows. Product descriptions do not establish independent clinical accuracy or improvements in patient outcomes.

Source, dates & preserved provenanceDeepScribe Inc. — Official product overview ↗

Authority: vendor owned
Observed 2026-11-02 · Reviewed 2026-11-02 · current until 2026-12-02

Artifact SHA-256: 722464adc803a1ba9efe5830572908163142a702f3e808099517cfe0a9a9142e

The hash identifies the preserved capture. The live source may have changed.

Source register

DeepScribe Inc. — Official product overview ↗vendor owned · captured 2026-11-02
DeepScribe Inc. — Official product overview ↗vendor owned · captured 2026-11-02
Brand asset provenance

Organization identity asset from its official website; inclusion does not imply endorsement.

Official website ↗ · Original asset ↗

04 / BEFORE YOU COMMIT

Better questions.
A clearer decision.

Resolve these with the provider and your own evaluation team.

01

Which service, plan, region and integrations does the proposed BAA cover?

02

What retention, deletion and model-training terms apply to our exact workflow?

03

Who validates outputs and owns the clinical or operational decision?

Regulatory applicability requires a separate, current determination. Inclusion is not certification.

COMPLIANCE / CLAIMS, SCOPE & GAPS

Start with the requirement.
Inspect the support.

Prepare your vendor review ↗

These labels describe this dossier’s current evidence coverage. A published mention may be a framework mapping, a qualified assertion or a limitation; it is not a compliance finding.

HIPAA

Published mention available

US healthcare privacy & security

Vendor documents BAA availability

Posted terms contain a BAA. The practice's agreement governs PHI handling, and order-form/service scope must be confirmed. AI output requires clinical review.

Read the source-attributed statement

DeepScribe's posted terms include a HIPAA business-associate agreement between DeepScribe and its healthcare customer. Buyers must confirm the applicable service and order form; the published text is not evidence that their own BAA has been executed.

vendor asserted

DeepScribe Inc. — Posted platform terms and HIPAA provisions ↗

Explore HIPAA evidence ↗

For HIPAA-regulated use, request service-specific BAA eligibility, processing scope and responsibility details. Missing evidence here does not establish noncompliance. Payment cannot alter these evidence labels.

KEEP THE RECORD USEFUL

A dossier should stand up to scrutiny.

Have a source that changes this picture? Submit it for editorial review.

Raise an evidence issue ↗